Engineering synthetic enhancers and gene circuits to understand and overcome cancer therapy resistance
Dauer: 48 Monate, Fördersumme: € 899.099
The impact of mast cell activation on epithelial and endothelial barrier dysregulation in post-infectious ME/CFS
Dauer: 12 Monate, Fördersumme: € 99.992
Multiscale discovery of cellular and microanatomical determinants of metastasis
Dauer: 48 Monate, Fördersumme: € 799.960
Lipid metabolism in granulomatous diseases
Dauer: 18 Monate, Fördersumme: € 74.930
Innate immune reprogramming to overcome therapy resistance in high-risk colorectal cancer
Dauer: 36 Monate, Fördersumme: € 800.000
Decoding cellular senescence in glioblastoma (GlioAge)
Dauer: 36 Monate, Fördersumme: € 898.970